PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

Not yet recruiting

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Lorlatinib

First Posted Date: 2024-11-07

Last Posted Date: 2025-05-07

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT06678555

Locations: 🇨🇳
Pfizer, Taipei, Taiwan

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase 3

Recruiting

Conditions: COVID-19 SARS-CoV-2 Infection

Interventions: Drug: ibuzatrelvir
Drug: placebo

First Posted Date: 2024-11-07

Last Posted Date: 2025-05-31

Lead Sponsor: Pfizer

Target Recruit Count: 2330

Registration Number: NCT06679140

Locations: 🇺🇸
Applied Research Center of Arkansas, Little Rock, Arkansas, United States
🇺🇸
National Institute of Clinical Research - Bakersfield, Bakersfield, California, United States
🇺🇸
310 Clinical Research, Inglewood, California, United States

and more 79 locations

A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants

Phase 1

Active, not recruiting

Conditions: Healthy

Interventions: Drug: PF-07275315
Other: Placebo

First Posted Date: 2024-11-05

Last Posted Date: 2025-05-11

Lead Sponsor: Pfizer

Target Recruit Count: 13

Registration Number: NCT06675188

Locations: 🇨🇳
Huashan Hospital,Fudan University, Shanghai, Shanghai, China

A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

Phase 1

Recruiting

Conditions: Acne Vulgaris

Interventions: Drug: PF-07905428
Drug: Placebo

First Posted Date: 2024-11-04

Last Posted Date: 2025-05-13

Lead Sponsor: Pfizer

Target Recruit Count: 52

Registration Number: NCT06671834

Locations: 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: PF-07976016 Formulation A
Drug: PF-07976016 Formulation B

First Posted Date: 2024-11-01

Last Posted Date: 2025-03-11

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT06670170

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: Treatment A
Drug: Treatment B
Drug: Treatment C
Drug: Treatment D

First Posted Date: 2024-10-28

Last Posted Date: 2025-04-24

Lead Sponsor: Pfizer

Target Recruit Count: 16

Registration Number: NCT06661694

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

Phase 1

Recruiting

Conditions: Healthy Participants

Interventions: Drug: PF-06414300
Drug: Placebo

First Posted Date: 2024-10-26

Last Posted Date: 2024-10-26

Lead Sponsor: Pfizer

Target Recruit Count: 61

Registration Number: NCT06659250

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

ATTR-CM: A Multi-country, Non-interventional Disease Registry

Recruiting

Conditions: Transthyretin Amyloid Cardiopathy

First Posted Date: 2024-10-21

Last Posted Date: 2025-05-08

Lead Sponsor: Pfizer

Target Recruit Count: 350

Registration Number: NCT06651073

Locations: 🇨🇳
National Taiwan University, Taipei City, Taiwan

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Active, not recruiting

Conditions: Respiratory Syncytial Virus
Respiratory Tract Diseases

Interventions: Biological: ABRYSVO

First Posted Date: 2024-10-18

Last Posted Date: 2025-05-25

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT06647654

Locations: 🇦🇷
Pfizer, Buenos Aires, Argentina

A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: ibuzatrelvir
Drug: carbamazepine ER

First Posted Date: 2024-10-17

Last Posted Date: 2025-02-03

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT06646042

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy